Promoted Content

Promoted Content

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Wildlife Pharmaceuticals

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

South Africa

Post An Enquiry

The Beverage Forum 2021

Participation Not Confirmed

Update your events

Wedgewood Pharmacy Completes Acquisition of Wildlife Pharmaceuticals and Its Subsidiary ZooPharm; Appoints New Wildlife General Manager

Contact the Supplier

Lead Product(s): Butorphanol,Azaperone,CAS 86347-15-1

Therapeutic Area: Neurology Product Name: BAM Kit

Highest Development Status: Undisclosed Product Type: Small molecule

Partner/Sponsor/Collaborator: Wedgewood Pharmacy

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition August 10, 2020

Details:

ZooPharm’s BAM™ Kit includes a patented combination of Butorphanol tartrate, Azaperone tartrate, and Medetomidine hydrochloride that is used to immobilize a broad range of species.